Now the recession is apparently over, global companies are back to thinking about the future...
Birmingham-based Midven, an investor in growing companies, has launched a new fund and made its first investment. Fundraising Deals / Friday, 5th March 2010
ApaTech, a specialist in bone repair technology, is to be sold for up to $330 million (£220 million) in a big win for its investors. Mergers & Acquisitions / Tuesday, 2nd March 2010
Immune Targeting Systems (ITS), a developer of vaccines for mutating viruses such as flu, has raised £8.65 million for initial clinical trials. Fundraising Deals / Thursday, 18th February 2010
New and existing investors have backed nanotechnology business Oxford Nanopore with an investment of £17.4 million. Fundraising Deals / Monday, 1st February 2010
Touch Bionics, which launched its “bionic fingers” worldwide in December, has received a £800,000 loan from its principal investors. Fundraising Deals / Thursday, 21st January 2010
Needle-free drug delivery company Ocelus has secured almost £500,000 in a second round of funding from Finance Wales and the Welsh Assembly. Fundraising Deals / Tuesday, 19th January 2010
London-based investor NBGI Ventures has led a $5 million (£3 million) Series B investment round into Advanced Cardiac Therapeutics. Fundraising Deals / Monday, 11th January 2010
Biotech company Q Chip has received £1 million in a funding round led by cleantech venture investor Curzon Park Capital. Fundraising Deals / Monday, 7th December 2009
Mid-market private equity firm Palamon Capital Partners has acquired a majority stake in Associated Dental Practices for £136 million. Mergers & Acquisitions / Tuesday, 1st December 2009
Scriptswitch, a provider of software for GPs, has been sold to US healthcare group UnitedHealth as backer ISIS exits the company. Mergers & Acquisitions / Thursday, 19th November 2009
Private equity firm NVM has sold its investment in offshore medics service Abermed to medical assistance provider International SOS. Mergers & Acquisitions / Tuesday, 17th November 2009
Lein Applied Diagnostics, a developer of non-invasive optical measurement technology, has raised £1 million from two investors. Fundraising Deals / Monday, 26th October 2009
The Mobius Life Sciences Fund has been launched by biotech incubator BioCity Nottingham to finance early-stage life sciences companies. Fundraising Deals / Wednesday, 30th September 2009
Medical diagnostics company DXS has been sold for as much as $130 million, leading to a ‘record exit’ for NVM Private Equity. Mergers & Acquisitions / Wednesday, 23rd September 2009
Keith Tozzi may have stumbled across the idea for drugs and alcohol testing provider Concateno, but there’s nothing fortuitous about the chairman’s approach to growing a business for a big sale. Flotation / Thursday, 20th August 2009
Data centre services provider CSF Group is seeking to raise £28 million for an AIM float at 55p. SMALL-CAP SPOTLIGHT / Monday, 15th March 2010
Mid-market investor NVM has bought a minority stake in software developer Lanner Group as the company's previous backer 3i exits the business. Mergers & Acquisitions / Monday, 15th March 2010
Aussie-based Cape Lambert Resources is selling its Lady Annie copper mine for A$135 million to Hong Kong-quoted China Sci-Tech. SMALL-CAP SPOTLIGHT / Friday, 12th March 2010
| Company | Type | Date |
|---|---|---|
| Jeyes | VC | Feb 2010 |
| Immune Targeting Systems | VC | Feb 2010 |
| Oxford Nutrascience | AIM | Feb 2010 |
| Ocelus | VC | Jan 2010 |
| Silence Therapeutics | AIM | Jan 2010 |
| HealthyDays | PLUS | Dec 2009 |
| Q Chip | VC | Dec 2009 |
| Associated Dental Practices | VC | Dec 2009 |
Discover the 12 key points your company should consider before you evaluate and select a vulnerability assessment solution.
Oracle 9i administrators can certify on Oracle 10G by passing this exam. The ExamForce 1Z0-040 Oracle Database 10G New Features for Administrators practice exam provides their unique triple testing mode to instantly set a baseline of your knowledge and focus your study where you need it most.
A Valuable Tool to Help You Assess the Strength and Potential of Your Screening Program.